SETD1A variant-associated psychosis: A systematic review of the clinical literature and description of two new cases

Prog Neuropsychopharmacol Biol Psychiatry. 2024 Feb 8:129:110888. doi: 10.1016/j.pnpbp.2023.110888. Epub 2023 Oct 31.

Abstract

Objective: SETD1A encodes a histone methyltransferase involved in various cell cycle regulatory processes. Loss-of-function SETD1A variants have been associated with numerous neurodevelopmental phenotypes, including intellectual disability and schizophrenia. While the association between rare coding variants in SETD1A and schizophrenia has achieved genome-wide significance by rare variant burden testing, only a few studies have described the psychiatric phenomenology of such individuals in detail. This systematic review and case report aims to characterize the neurodevelopmental and psychiatric phenotypes of SETD1A variant-associated schizophrenia.

Methods: A PubMed search was completed in July 2022 and updated in May 2023. Only studies that reported individuals with a SETD1A variant as well as a primary psychotic disorder were ultimately included. Additionally, another two previously unpublished cases of SETD1A variant-associated psychosis from our own sequencing cohort are described.

Results: The search yielded 32 articles. While 15 articles met inclusion criteria, only five provided case descriptions. In total, phenotypic information was available for 11 individuals, in addition to our own two unpublished cases. Our findings suggest that although individuals with SETD1A variant-associated schizophrenia may share a number of common features, phenotypic variability nonetheless exists. Moreover, although such individuals may exhibit numerous other neurodevelopmental features suggestive of the syndrome, their psychiatric presentations appear to be similar to those of general schizophrenia populations.

Conclusions: Loss-of-function SETD1A variants may underlie the development of psychosis in a small percentage of individuals with schizophrenia. Identifying such individuals may become increasingly important, given the potential for advances in precision medicine treatment approaches.

Keywords: Psychiatric genetics; Psychosis; SETD1A; Schizophrenia.

Publication types

  • Systematic Review
  • Case Reports
  • Review

MeSH terms

  • Genetic Predisposition to Disease
  • Humans
  • Intellectual Disability* / genetics
  • Phenotype
  • Psychotic Disorders* / genetics
  • Psychotic Disorders* / psychology
  • Schizophrenia* / genetics

Substances

  • Setd1A protein, human